Ruben Raychaudhuri

Ruben Raychaudhuri is an Assistant Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and an Assistant Professor in the Clinical Research Division at Fred Hutchinson Cancer Center. His clinical practice spans multiple sites including Fred Hutchinson Cancer Center - South Lake Union, Fred Hutch at UW Medical Center – Montlake, and Fred Hutch at UW Medical Center- Northwest Hospital.

• M.D. from Medical College of Wisconsin
• Residency at Hospital of the University of Pennsylvania Health System
• Fellowship in Hematology/Medical Oncology at Fred Hutch Cancer Center
• Certified in Internal Medicine by the American Board of Internal Medicine

Dr. Raychaudhuri specializes in the care of patients with genitourinary cancers, particularly prostate, bladder, and testicular cancer. His research focuses on translating scientific discoveries into clinical practice through novel molecularly targeted therapies and biomarker identification to inform personalized therapeutic decisions. He is actively involved in numerous clinical trials aimed at improving outcomes for patients with genitourinary malignancies.

His recent publications (2020-2025) demonstrate a strong focus on prostate cancer treatment advancements, particularly in the areas of PSMA-targeted radiopharmaceutical therapy, PARP inhibitors, and precision medicine approaches. His work also extends to bladder cancer immunotherapy, lymphoma treatments, and clinical trials evaluating novel therapeutic combinations for advanced genitourinary cancers.

Dr. Raychaudhuri collaborates extensively with researchers across multiple institutions, as evidenced by his numerous multi-institutional publications. His work bridges basic science discoveries with clinical applications, emphasizing personalized treatment approaches based on genomic and molecular characteristics of individual tumors.